| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |